Nephrogenic diabetes insipidus: genes and variants
Explore variant evidence for Nephrogenic diabetes insipidus across 2 analyzed proteins (AQP2, AVPR2). Linked ClinVar records include 26 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 2 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Nephrogenic diabetes insipidus
AQP2: Aquaporin-2
It is inserted into the collecting-duct apical membrane in response to vasopressin, allowing water reabsorption and concentration of urine. Pathogenic variants cause nephrogenic diabetes insipidus, usually recessive for loss-of-function alleles and sometimes dominant through abnormal intracellular trafficking.
19 ClinVar pathogenic / likely pathogenic and 8 uncertain variants in AQP2 have source records linked to Nephrogenic diabetes insipidus. Association strength is not clinical gene validity.
AVPR2: Vasopressin V2 receptor
A vasopressin receptor in kidney collecting-duct cells that activates cAMP signaling and promotes insertion of aquaporin-2 water channels. Pathogenic variants can cause X-linked nephrogenic diabetes insipidus.
7 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in AVPR2 have source records linked to Nephrogenic diabetes insipidus. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Nephrogenic diabetes insipidus
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| AQP2 R187H | 187 | Discontinuously helical | Pathogenic / likely pathogenic (★★) |
| AQP2 R187C | 187 | Discontinuously helical | Pathogenic / likely pathogenic (★★) |
| AQP2 G64R | 64 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| AVPR2 R137H | 137 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| AQP2 A47V | 47 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AVPR2 P322L | 322 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AQP2 Q57P | 57 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AQP2 G100V | 100 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AQP2 A147T | 147 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AQP2 V168M | 168 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AVPR2 R104C | 104 | Extracellular | Pathogenic / likely pathogenic (★★) |
| AVPR2 Y205C | 205 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| AQP2 T126M | 126 | Extracellular | Pathogenic / likely pathogenic (★★) |
| AQP2 T125M | 125 | Extracellular | Pathogenic / likely pathogenic (★★) |
| AQP2 P185A | 185 | Discontinuously helical | Pathogenic / likely pathogenic (★★) |
| AQP2 P262L | 262 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| AVPR2 P322T | 322 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AQP2 G175R | 175 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AQP2 A190T | 190 | Discontinuously helical | Pathogenic / likely pathogenic (★) |
| AQP2 S216P | 216 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AVPR2 L59P | 59 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AQP2 E258K | 258 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| AVPR2 A285P | 285 | Transmembrane | Pathogenic / likely pathogenic (★) |
| AQP2 M1I | 1 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| AQP2 C75G | 75 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| AQP2 R254Q | 254 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
Which prediction tools work for Nephrogenic diabetes insipidus
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MutPred: 100 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- MetaLR: 97 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 94 out of 100
- phyloP: 91 out of 100
- SIFT: 87 out of 100
- ESM1b (LLR): 86 out of 100
- PolyPhen-2: 86 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 60 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 57 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Diabetes insipidus, nephrogenic, autosomal also has ClinVar records linked to AQP2 variants; they fall mostly in different places as the Nephrogenic diabetes insipidus variants (16 pathogenic / likely pathogenic).
- Diabetes insipidus, nephrogenic, X-linked also has ClinVar records linked to AVPR2 variants; they fall mostly in different places as the Nephrogenic diabetes insipidus variants (25 pathogenic / likely pathogenic).
- Nephrogenic syndrome of inappropriate antidiuresis also has ClinVar records linked to AVPR2 variants; they fall partly in the same places as the Nephrogenic diabetes insipidus variants (7 pathogenic / likely pathogenic).
Diseases related to Nephrogenic diabetes insipidus
- Diabetes insipidus, nephrogenic, X-linked, also linked to AVPR2
- Renal tubulopathies, also linked to AVPR2
- Diabetes insipidus, nephrogenic, autosomal, also linked to AQP2
- Autosomal dominant polycystic kidney disease, also linked to AVPR2
- Nephrogenic syndrome of inappropriate antidiuresis, also linked to AVPR2
Frequently asked questions
Which genes have records linked to Nephrogenic diabetes insipidus?
This view contains 2 analyzed proteins: AQP2, AVPR2. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 26 pathogenic or likely pathogenic variants, 6 variants of uncertain significance and 2 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 104 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center